buthionine sulfoximine has been researched along with Experimental Hepatoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, S; Lu, H; Sun, K; Taylor, EW; Wan, X; Wang, D; Wang, Y; Zhang, J | 1 |
| Boku, Y; Hara, T; Kokura, S; Naito, Y; Nakagawa, S; Yoshida, N; Yoshikawa, T | 1 |
| Asakura, T; Inoue, T; Ohkawa, K; Takada, K; Takahashi, N; Yokoyama, S | 1 |
| Mulder, GJ; Schutrups, J; Vahrmeijer, AL; van de Velde, CJ; van Dierendonck, JH | 1 |
| Benchekroun, MN; Catroux, P; Montaudon, D; Robert, J | 1 |
| Dierickx, PJ | 1 |
| Dikdan, G; Dimaira, MJ; Hu, JJ; Lea, MA; Zirvi, KA | 1 |
7 other study(ies) available for buthionine sulfoximine and Experimental Hepatoma
| Article | Year |
|---|---|
Inhibition of glutathione synthesis eliminates the adaptive response of ascitic hepatoma 22 cells to nedaplatin that targets thioredoxin reductase.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Ascites; Buthionine Sulfoximine; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Flow Cytometry; Glutathione; Liver Neoplasms, Experimental; Male; Mice; Organoplatinum Compounds; Random Allocation; Thioredoxin-Disulfide Reductase | 2012 |
Enhancement of lipid peroxidation and of the antitumor effect of hyperthermia upon combination with oral eicosapentaenoic acid.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antioxidants; Arachidonic Acids; Buthionine Sulfoximine; Carcinoma; Drug Screening Assays, Antitumor; Fatty Acids, Unsaturated; Glutathione Peroxidase; Hyperthermia, Induced; Lipid Peroxidation; Liver; Liver Neoplasms, Experimental; Male; Oxidation-Reduction; Rats; Stimulation, Chemical; Thiobarbituric Acid Reactive Substances | 2002 |
Glutathione-doxorubicin conjugate expresses potent cytotoxicity by suppression of glutathione S-transferase activity: comparison between doxorubicin-sensitive and -resistant rat hepatoma cells.
Topics: Animals; Antibiotics, Antineoplastic; Buthionine Sulfoximine; Doxorubicin; Drug Resistance, Neoplasm; Glutathione; Glutathione Transferase; Liver Neoplasms, Experimental; Rats; Trialkyltin Compounds; Tumor Cells, Cultured | 1997 |
Potentiation of the cytostatic effect of melphalan on colorectal cancer hepatic metastases by infusion of buthionine sulfoximine (BSO) in the rat: enhanced tumor glutathione depletion by infusion of BSO in the hepatic artery.
Topics: Animals; Buthionine Sulfoximine; Colorectal Neoplasms; Drug Synergism; Glutathione; Infusions, Intra-Arterial; Liver Neoplasms, Experimental; Male; Melphalan; Rats | 1999 |
Development of mechanisms of protection against oxidative stress in doxorubicin-resistant rat tumoral cells in culture.
Topics: Animals; Brain Neoplasms; Buthionine Sulfoximine; Doxorubicin; Drug Resistance; Free Radicals; Glioblastoma; Glutathione; Lipid Peroxidation; Liver Neoplasms, Experimental; Membrane Glycoproteins; Methionine Sulfoximine; Oxidation-Reduction; Rats; Tumor Cells, Cultured; Vitamin E | 1990 |
Long-term buthionine-sulfoximine-mediated toxicity in cultured hepatoma cell lines.
Topics: Animals; Antimetabolites; Buthionine Sulfoximine; Carcinoma, Hepatocellular; Cell Survival; Female; Glutathione; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Methionine Sulfoximine; Neoplasm Proteins; Time Factors; Tumor Cells, Cultured | 1990 |
Influence of pH on the modification of thiols by carbamoylating agents and effects on glutathione levels in normal and neoplastic cells.
Topics: Animals; Buthionine Sulfoximine; Carbamates; Colonic Neoplasms; Cyanates; DNA, Neoplasm; Glutathione; Humans; Hydrogen-Ion Concentration; Kinetics; Liver; Liver Neoplasms, Experimental; Methionine Sulfoximine; Protein Biosynthesis; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Tumor Cells, Cultured | 1989 |